In this issue Chris Tachibana takes a closer look at what impact closing a country’s borders has on science recognition. Our profile is Britt Meelby Jensen, CEO of the Danish biotech company Zealand Pharma, and in our Nordic cities series we have arrived at the capitals Stockholm, Oslo, Helsinki and Copenhagen. We also learn more about life science law, how bones may act as internal scales that monitor weight and we summarizes the most important life science events from the past quarter.
Sign up for a subscription here!
